July 18-20, 2013
8th International NOSCAR® Summit
ASGE IT&T Center
Early Bird Registration is now open! (Fees increase after June 20, 2013)
Exploring the latest scientific information on Peroral Endoscopic Myotomy (POEM), Endoscopic Submucosal Dissection (ESD) and Natural Orifice Translumenal Endoscopic Surgery® (NOTES®), the 2013 NOSCAR Summit will bring together leaders from around the world to discuss current therapeutic endoscopic procedures, surgical techniques and innovative devices and accessories. Registration will open in early February. Visit www.noscar.org soon for more information on the program and presenters for this outstanding educational opportunity which will be held at ASGE’s new, state-of-the-art IT&T Center.
Click here for Agenda
Lodging:
Double Tree Suites by Hilton, 2111 Butterfield Road, Downers Grove, Illinois 60515
Direct Phone Number: 1-630-971-2000
For Reservations: 1-800-445-8667 or 1-630-971-2000. ( Please reference the NOSCAR room block)
Room rate: US$109 (+ tax)
NOSCAR® Increases NOTES® Research with Olympus Medical Systems
Corporation Grant
OAK BROOK, Ill., July 11, 2009 – The Natural Orifice Surgery Consortium for Assessment and Research® (NOSCAR®), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), today announced Olympus’ continuing commitment to funding research in an emerging minimally invasive transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery®, with a $250,000 grant to the existing Olympus Research Fund supporting NOTES® research. This grant increases Olympus’ total funding to $1.25 million.
Read More…
NOSCAR® Announces NOTES® Multicenter Human Trials in the U.S.
OAK BROOK, Ill., July 10, 2009 – The Natural Orifice Surgery Consortium for Assessment and Research® (NOSCAR®), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announces the first Natural Orifice Translumenal Endoscopic Surgery® (NOTES®) multicenter human trial in the United States. Until now, NOSCAR research efforts have focused on basic research. The next phase will involve critical human trials. Continuing research commitments from industry partners Ethicon Endo-Surgery, Olympus America Inc. and Stryker Medical will provide funds to support the study in this emerging transdisciplinary therapy. The landmark study was announced at the 4th International Conference on NOTES in Boston where nearly 300 physicians and industry representatives gathered to learn the latest information about the science and technology of the medical platform.
Read More…
NOSCAR™ Announces 2008 NOTES™ Research Award Winners
OAK BROOK, Ill., September 12, 2008 – The Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR™), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announce the 2008 NOSCAR™ Research Award winners. The funds, granted through Olympus Medical Systems’ Olympus Research Fund and by KARL STORZ Endoscopy-America, Inc., will be distributed among 14 grant recipients supporting 16 research projects in the emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery™ (NOTES™), an approach that could ultimately represent a major paradigm shift in minimally invasive therapy and patient care. NOSCAR™ received 32 grant applications for the $750,000 in research funds.
Read More…
NOSCAR™ Debuts NOTES™/ NOSCAR™ Outcomes Registry
OAK BROOK, Ill., August 18, 2008 – The Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR™), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), have created an outcomes registry for physicians worldwide to log human research cases in an emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery™ (NOTES™). The NOTES™/NOSCAR™ Outcomes Registry, which began tracking procedures in July during the 3rd International Conference on NOTES™ held in San Francisco, Calif., is a next step in the continuing evolution of this minimally invasive procedure.
Read More…
NOTES® RESEARCH ACTIVITIES INCREASE WITH GRANTS FROM OLYMPUS MEDICAL SYSTEMS TOTALING $1 MILLION
OAK BROOK, Ill., July 10, 2008 – The Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR® ), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), today announced Olympus’ continuing commitment to funding research in an emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery™ (NOTES®), with a $500,000 grant to the existing Olympus Research Fund supporting NOTES® research. The grant increases Olympus’ total funding to $1 million. NOTES®, which is performed by using the patient’s natural openings for surgery, will be discussed among researchers from July 10-12, 2008 at the 3rd International Conference on NOTES® in San Francisco, Calif.
Read More…
$500,000 COVIDIEN GRANT HELPS FUND INCREASED RESEARCH ACTIVITIES BY GI SOCIETIES
BOSTON, Massachusetts – July 12, 2007 – Covidien, a leading global provider of healthcare products, announced today that its Surgical Devices business unit has provided a $500,000 grant to the Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR® ) to establish the Covidien NOTES® Research Fund.
October 2006LEADING GI MEDICAL & SURGICAL SOCIETIES PARTNER WITH ETHICON ENDO-SURGERY TO ADVANCE REVOLUTIONARY RESEARCH
October 11, 2006 – Oak Brook, Ill. – The Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR), a joint effort of The American Society for Gastrointestinal Endoscopy (ASGE) and The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announces a Request for Proposals based on a pledge of $1,000,000 in research funds from Ethicon Endo-Surgery. This investment will support fundamental research in an emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery (NOTES)™, an approach that could ultimately represent a major paradigm shift in minimally invasive therapy.
“As a company committed to surgical innovation, Ethicon Endo-Surgery is proud to support critical research in this emerging therapeutic approach,” said Kevin Lobo, President, Ethicon Endo-Surgery. “We’re pleased to support research that will help the NOSCAR partnership explore what potentially may be the next frontier in surgery. As Ethicon Endo-Surgery moves into new and different procedures with new technology, we believe funding the responsible, effective and safe development of this new modality may lead to important surgical innovations.”